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Background: The development of resistant to current antimalarial drugs is a major challenge in achieving malaria
elimination status in many countries. Therefore there is a need for new antimalarial drugs. Medicinal plants have
always been the major source for the search of new antimalarial drugs. The aim of this study was to screen
selected Malaysian medicinal plants for their antiplasmodial properties.
Methods: Each part of the plants were processed, defatted by hexane and sequentially extracted with dichloromethane,
methanol and water. The antiplasmodial activities of 54 plant extracts from 14 species were determined by Plasmodium
falciparum Histidine Rich Protein II ELISA technique. In order to determine the selectivity index (SI), all plant extracts
demonstrating a good antiplasmodial activity were tested for their cytotoxicity activity against normal Madin-Darby
Bovine Kidney (MDBK) cell lines by 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay.
Results: Twenty three extracts derived from Curcuma zedoaria (rhizome), Curcuma aeruginosa (rhizome), Alpinia galanga
(rhizome), Morinda elliptica (leaf), Curcuma mangga (rhizome), Elephantopus scaber (leaf), Vitex negundo (leaf), Brucea
javanica (leaf, root and seed), Annona muricata (leaf), Cinnamomun iners (leaf) and Vernonia amygdalina (leaf) showed
promising antiplasmodial activities against the blood stage chloroquine resistant P. falciparum (EC50 < 10 μg/ml) with
negligible toxicity effect to MDBK cells in vitro (SI ≥10).
Conclusion: The extracts belonging to eleven plant species were able to perturb the growth of chloroquine resistant P.
falciparum effectively. The findings justified the bioassay guided fractionation on these plants for the search of potent
antimalarial compounds or formulation of standardized extracts which may enhance the antimalarial effect in vitro and
in vivo.Background
Malaria is one of the major public health problems in
many tropical regions, including Malaysia. The resistance
Plasmodium falciparum to common antimalarial drugs
such as chloroquine, sulfadoxine-pyrimethamine [1-3] and
artemisinin [4] have been reported. In response to this
situation, as recommended by World Health Organization
(WHO), Malaysian government has changed its first line
antimalarial drug regimen to artemisinin-based combin-
ation therapy (ACT) such as the use of fixed dose
artemether-lumefantrine combination (Riamet®) in the* Correspondence: eezoo79@gmail.com
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article, unless otherwise stated.treatment of uncomplicated falciparum malaria (National
Antibiotic Guideline 2008, Ministry of Health, Malaysia).
However, the ability of the malaria parasite such as P. fal-
ciparum to develop and become resistant to ACT in the
future cannot be denied [5-9]. Therefore, discovering new
antimalarial drugs is a priority in the health sector. The
challenges in malaria drug discovery are to find safe, cheap
and effective antimalarial agents.
Plants have always been the main source for the search
of new antimalarial drugs. Until the year of 2003, 1277
plant species from 160 families have been published by
33 tropical countries for their use in treatment of mal-
aria and fevers [10]. In Peninsular Malaysia, about 21
plant species are used by the locals as traditional medi-
cine for malaria treatment [11-13]. So, it is of pivotal tod Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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a major role in killing the malaria parasites. Thus,
screening the plant extracts for antimalarial properties
prior to bioassay guided fractionation and potent com-
pound isolation is important.
Research on the effectiveness of medicinal plant ex-
tracts in inhibiting the growth of malaria parasite has
been extensively studied worldwide. One good example
is Artemisia annua where whole leaves extract of thisTable 1 The list of Malaysian medicinal plants with potential
Plant species Local name
Agathis borneensis Raja Kayu
Alpinia galanga Lengkuas
Alstonia angustiloba Akar Lumut
Alyxia lucida Mempelas Hari
Andrographis paniculata Hempedu Bumi
Ardisia crenata Mata Ayam









Eurycoma longifolia Tongkat Ali
Goniothalamus macrophyllus Selada
Goniothalamus scorthechinii Selada Putih
Gynura procumbens Sambung Nyawa
Jasminum sambac Melati
Kopsia fruticosa Chabai Hutan
Lansium domesticum Langsat
Leuconotis eugenifolius Cheret Murai
Macaranga triloba Mahang Merah








Vallaris glabra Kerak nasi
Xylocarpus granatum Nyireh
Extracts of these plants have been reported for their antiplasmodial (in vitro) and/o
to 2013.plant has exhibited better antiplasmodial activity as
compared to its isolated compound, artemisinin [14,15].
This shows that there are other unidentified compounds
still remain in this plant.
Many of medicinal plants which grow in Malaysian
soil have been reported by the local scientists for their
antiplasmodial activities in vitro and in vivo (Table 1). In
this study, another 14 selected Malaysian medicinal




































r antimalarial (in vivo) activities by the Malaysian researchers from year 1995
Table 2 The list of 14 Malaysian medicinal plants and its traditional claims and treatments












Melada pahit Leaf: Used as a poultice for scurf, ringworm, boils, centipede
bites and over enlarged spleen in fever. Root: Used as a decoction
for colic, dysentery, fever, bodily pain and labour pain. Fruit and
leaf: Used as an infusion to cure malaria.
UKMB40227
Leeaceae Leea indica Mali-mali, memali Leaf: Used as a poultice in skin complaints caused by poisonous













Leaf: Used as a remedy for cleansing the birth canal and increase




Ketapang Bark: Act as astringent in dysentery Leaf: Act as a sudorific and applied






Leaf: Added to rice for loss of appetite, taken for head ache, cholera,
diarrhoea and fever. Applied in a pounded condition upon the spleen




Durian belanda Leaf: Used as a poultice or an infusion externally for skin complaints






Used as a decoction (leaf or root) for preventive medicine after childbirth,
in tonics, to drive out round worm, for coughs and veneral disease. The
leaf decoction used as an antihelmintic, as a diuretic and for abdominal
















Rhizome: Used as a tonic, for a cough and asthma. Externally used




Lengkuas Rhizome: Used as a decoction to cure malaria. Carminative, stomachic




Temu merah Rhizome: Used by the local to treat tumours RZ19/10
As referred in [11,36] and Global Information Hub in Integrated Medicine (www.globinmed.com).
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site, chloroquine (CQ) resistant P. falciparum (K1)
in vitro by using P. falciparum Histidine Rich Protein II
(HRP2) ELISA technique [16].Methods
Plant collection and identification
All plant parts except Brucea javanica and Annona mur-
icata were collected from the herbal garden of Herbal
Medicine Research Centre (HMRC), Institute for Med-
ical Research (IMR), Kuala Lumpur, Malaysia. Both B.
javanica and A. muricata were collected from Northern
part of Peninsular Malaysia, Tupah Village, Kedah
andMalaysian Agricultural Research and Development
Institute (MARDI), Kedah, respectively. All plants parts
except B. javanica, Curcuma aeruginosa, C. mangga, C.phaeocaulis were identified and authenticated by Dr.
Richard Chung Cheng Kong and deposited in the Herb-
arium of Forest Research Institute Malaysia (FRIM),
Kepong, Kuala Lumpur. The B. javanica was identified
and authenticated by Mr. Sani Miran and deposited in
the Herbarium of the Universiti Kebangsaan Malaysia
(UKM), Bangi, Selangor, Malaysia. The Curcuma species
were identified and deposited in the Herbarium of
Herbal Medicine Research Centre, Institute for Medical
Research, Kuala Lumpur, Malaysia.Plant extract preparation
The fresh plant materials (rhizome, leaf, root and seed)
were cut into small pieces, dried and pulverized into
powder before extraction with solvents in increasing po-











(MeOH) Water extract 
(H2O) 
Dried and grinded 
Defatted with hexane at 
room temperature. 
Extraction of dried residue 
with dichloromethane at 
room temperature. 
Extraction of dried residue 
with methanol at room 
temperature. 
Filtered and concentrated using 
rotary evaporator (40oC) 
Extraction of dried residue 
with water (80oC) and 
concentrated using freeze-
dryer  
Filtered and concentrated using 
rotary evaporator (40oC) 
Filtered and concentrated using 
rotary evaporator (40oC) 
Figure 1 Procedure of plant extraction. Different part of plants was extracted sequentially by using organic solvents (DCM and MeOH) with
increasing polarity.
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chloromethane (DCM), methanol (MeOH) and sterile
deionised water (H2O) (80°C). Briefly, the resulting solu-
tions from the first extraction using DCM were filtered
through filter paper (Whatman No.1, England) to collect
the supernatant from the residue. Organic supernatant
were evaporated to dryness under reduced pressure with a
rotary evaporator (Buchi Rotavapor R-200, Switzerland) at
a temperature 40°C. The residue was further extracted by
using MeOH similar to the procedure that carried out for
the DCM. The resulting residue was air dried and used for
further extraction with sterile H2O at 80°C. The aqueous
supernatant were freeze-dried to obtain crude extracts(Figure 1). All crude extracts (DCM, MeOH and H2O)
were stored at 4°C until used.
The mammalian cells and parasites
The CQ resistant P. falciparum strain, K1 was obtained
from American Type Culture Collection (ATCC), The
Malaria Research and Reference Reagent Resource Cen-
ter (MR4). Madin-Darby Bovine Kidney (MDBK) cells
were also obtained from ATCC. The cryopreserved para-
sites and cells were thawed and maintained in culture
for further use in this study. Briefly, the cryopreserved
parasites were thawed in waterbath at 37°C. The thawed
parasites were transferred into 15 ml conical tubes and
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added drop wise and swirled to mix. The mixtures were
centrifuged at 500 × g for 5 minutes and the supernatants
were discarded. These steps were repeated twice before
adding the complete RPMI 1640 culture medium (Invi-
trogen, USA) containing 25 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 0.2% sodium
bicarbonate (NaHCO3), 0.02 mg/ml gentamycin supple-
mented with 10% AB+ human serum (Invitrogen, USA).
For MDBK cells, the cryopreserved cells were thawed
immediately in the waterbath at 37°C. The thawed cells
were transferred in 15 ml conical tubes containing 1 ml
of complete DMEM culture medium (Invitrogen, USA)
containing 25 mM HEPES, 0.4% sodium bicarbonate
(NaHCO3), 100U of Penstrep (100U penicillin and 100U
streptomycin) supplemented with 10% fetal bovine
serum (FBS). The mixtures were centrifuged at 1000 × g,
4°C for 5 minutes. The supernatants were discarded.
The cell pellets were transferred into 25 cm2 culture
flask containing 5 ml of complete DMEM culture
medium. The suspension were mixed gently and incu-
bated in 5% carbon dioxide (CO2) incubator at 37°C.In vitro culture and synchronization of P. falciparum
The CQ resistant P. falciparum were grown by candle
jar technique (3% CO2 and 17% O2) [37]. The culture
was set up in a 25 cm3 culture flask with filtered vent
and maintained in complete RPMI 1640 culture medium
(Invitrogen, USA). The P. falciparum was grown in ‘O’
type fresh red blood cell (RBC) with the initial culture
started with 1% parasitemia at 2.5% hematocrit. The
parasite density was monitored daily by making thin
blood smears stained with 10% Giemsa solution and ob-
served under the microscope at 1000 times magnifica-
tion. When the parasitemia of the parasite culture
reached approximately 5 to 7%, the parasites were syn-
chronized using 5% sorbitol [38] and cultured for one
complete cycle prior to be used in in vitro P. falciparum
HRP2 assay.In vitro P. falciparum HRP2 assay
All crude extracts were evaluated in vitro for their anti-
plasmodial activities by HRP2 assay [16,39]. The extracts
were solubilised in 100% dimethyl sulphoxide (DMSO)
or sterile H2O (H2O extracts only) to get 5 mg/ml
stocks. In preparation of extract or drug stock plates, the
extracts (5 mg/ml) were serially diluted (2 fold dilution) to
7 point concentrations (ranging from 5 to 0.08 mg/ml) in
DMSO from well A1 to A7 in a 96 well plate. Fifteen
microliters of serially diluted stock extracts were trans-
ferred correspondingly into watery plates containing
225 μl of sterile H2O. An aliquote of watery plates will be
used in HRP2 assay.Ring-infected RBCs with 5% parasitemia were adjusted
to 0.05% parasitemia and 1.5% hematocrit. A total of
190 μl parasitized RBCs at 1.5% hematocrit were added
into each well of the test plates. A total of 10 μl of seri-
ally diluted extracts from the watery plates prepared
above were transferred into the test plates containing
parasitized RBCs and incubated in a candle jar at 37°C
for 72 hours. The final tested concentration ranging
from 16 to 0.2 μg/ml. The final concentration of DMSO
was 0.3%. Chloroquine (CQ) (Sigma, USA), quinine (Q)
(Sigma, USA), mefloquine (Mef) (Sigma, USA) and arte-
misinine (Art) (Sigma, USA) were used as standard con-
trol to validate the test. The final tested concentration
for standard control ranged from 1772.6 to 27.7 nM for
CQ, 3495 to 54.6 nM for Q, 601.3 to 9.4 nM for Mef
and 51.2 to 0.8 nM for Art. The negative control was
the infected RBC without extracts or with sterile H2O
only. After 72 hours of incubation, the test plates were
kept in -80°C overnight. The plates were thawed at room
temperature to lyse the infected RBCs. The activity of
the parasite-extract exposure (end point) was measured
by HRP2 assay. One day prior to the assay, 100 μl of im-
munoglobulin M (IgM) capture antibody (MPFM-55A,
ICL, Inc, Newberg, OR, USA) specific for P. falciparum
HRP2 (1 μg/ml in phosphate-buffered saline (PBS)) were
added to each well of a 96-well ELISA plates (Microlon
600, Greiner, Germany). The plates were covered and in-
cubated at 4°C overnight. Following incubation, the con-
tents of the wells were removed and the plates were
washed three times with 0.05% PBS-Tween 20 (PBST).
The non-binding sites of the ELISA plates were blocked
with 200 μl/well of 2% bovine serum albumin in PBS for
2 hours at room temperature. Following the blocking
step, the ELISA plates were washed 3 times with 200 μl
of 0.05% PBST. Hundred microliters of the P. falciparum
infected RBC lysates (freeze thawed) were transferred
from the test plates into ELISA plates and incubated in
humidity chamber for 1 hour at room temperature. The
ELISA plates were washed as described above. Hundred
microliters of the detector antibody (MPFG-55P, ICL,
Inc, Newberg, OR, USA) conjugated with horseradish
peroxidase (0.2 μg/ml in PBS) were added to each well,
and incubated in humid chamber for 1 hour at room
temperature. Following a subsequent washing step simi-
lar to the above, 100 μl of 3,3’, 5,5;-tetramethylbenzidine
(TMB) chromogen (Zymed Lab., Inc., San Francisco,
CA, USA) was added to each well and incubated for
10 min in dark, followed by the addition of 50 μl of 1 M
sulphuric acid. The absorbance was determined by using
ELISA plate reader at a wavelength of 450 nm (FLUOs-
tar Omega, Germany). The collected data were trans-
ferred to HN-nonLin software (malaria.farch.net) to get
a 50% Effective Concentration (EC50) value directly from
the graph.
Table 3 Representative of in vitro antiplasmodial activity







Data are presented as mean of three independent experiments performed in
duplicate assays.
The in vitro P. falciparum HRP2 assay for standard antimalarial drugs were
conducted in parallel with the test plant extracts. Each of the assay were
validated based on the EC50 threshold for each standard antimalarial drugs
against the P. falciparum K1 strain in the lab. If the EC50 value of the standard
antimalarial drugs are out of range, the test considered invalid.
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The MDBK cells were maintained in complete DMEM
culture medium containing 25 mM HEPES, 0.4% sodium
bicarbonate (NaHCO3), 100U of Penstrep (100U penicil-
lin and 100U streptomycin) supplemented with 10% fetal
bovine serum (FBS). The cytotoxicity of the extracts
were measured by 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) assay [40]. Prior to
the day of test, the stock plates were prepared by serially
diluting (2 fold dilution) the stock extracts (5 mg/ml) to
7 point concentration (ranging from 5 to 0.16 mg/ml)
with DMSO or sterile H2O (for H2O extracts only).
Then, 6 μl of serially diluted stocks were transferred into
96 well plates containing 294 μl of complete DMEM
media (Medium plates). On the day of the test, MDBK
cells were harvested and adjusted to 1 × 104 cell per ml.
A hundred microliter of cell suspension was seeded into
each well of a 96-well plate and allowed to grow over-
night. Then, 100 μl of test extracts taken from medium
plate (as prepared above) were added to each well ac-
cordingly ranging final concentration of 0.8 to 50 μg/ml.
The final concentration of DMSO in all test was less
than 1%. All tests were performed in duplicate. The
positive control for cell growth is the cell suspension
without test substance while the negative control is the
cell suspension with 0.05% Triton X 100. The culture
was incubated at 37°C in 5% CO2 incubator for 72 hours.
Fifty microliters of MTT solution (5 mg MTT in 1 ml
PBS and 2.5 ml DMEM media) were added to each well.
The plates were further incubated for 4 hours at 37°C in
5% CO2 incubator. The medium was removed and re-
placed with 200 μl of DMSO to solubilise the MTT for-
mazan product. The solution was mixed for 15 min and
once for 30 sec before measuring the absorbance at
540 nm with a micro plate reader (FLUOstar Omega,
Germany). The percentage of growth inhibition and the
EC50 were estimated from a dose response curve.
Determination of a selectivity index
A selectivity index (SI), corresponding to the ratio be-
tween antiplasmodial and cytotoxic activities was calcu-
lated according to the following formula:
SIPlasmodium ¼ EC50 normal cell lines=EC50Plasmodium
Results
Antiplasmodial activity against CQ resistant P. falciparum,
K1 strain
A total of 54 extracts from different parts of 14 plant spe-
cies (Table 2) were tested for antiplasmodial activity against
chloroquine resistant P. falciparum by using HRP2 assay
in vitro. Each part of the plants was extracted by 3 different
solvents with increasing polarity (DCM-MeOH-H2O). Thediscrimination of active extracts is based on ranked levels
of antiplasmodial activity proposed by Rasoanaivo et al.
[41]. The score for the test is classified as extracts with
EC50 value less than 0.1 μg/ml is considered to be very
good, 0.1 to 1.0 μg/ml is good, 1.1 to 10 μg/ml is good to
moderate, 11 to 25 μg/ml is weak, 26 to 50 μg/ml is very
weak while more than 100 μg/ml is considered inactive
[41]. So, any extracts which exhibit an EC50 value less than
10 μg/ml (EC50 ≤ 10 μg/ml) is considered to have potential
or promising antiplasmodial activity. The antiplasmodial
HRP2 assay on the plant extracts were performed in paral-
lel with the standard antimalarial drugs such as CQ, Q,
Mef and Art which act as a control for the validity of the
assay (Table 3). Briefly, the results of each assay were vali-
dated by determination of EC50 values produced by the
standard antimalarial drugs against CQ resistant P. falcip-
arum. In this study, the assay is considered valid when the
EC50 value of CQ is more than 100 nM [42].
The DCM, MeOH and H2O extracts from 14 plants
species showed wide range of antiplasmodial activities
(Table 4). Overall 41 extracts (76%) from 13 plant spe-
cies showed promising antiplasmodial activity (EC50 <
10 μg/ml) (Table 5). In detail, there are 11 extracts from
5 plant species fall within a good level of antiplasmodial
activity (EC50 < 1 μg/ml) (Table 5). Good to moderate
antiplasmodial activities (EC50 = 1.1-10 μg/ml) were de-
tected in 30 extracts from 12 plant species (Table 5).
Thirteen extracts from 6 plant species were considered
weak or inactive as these extracts exhibited EC50 values
of more than 10 μg/ml or less than 50% parasite inhibition
at the highest tested concentration (EC50 > 15.7 μg/ml)
(Table 5). Overall, DCM and MeOH extracts were more
active against CQ resistant P. falciparum with good level
of antiplasmodial activity (Table 5).
Cytotoxicity activity to mammalian MDBK cell line
Forty one extracts from 13 different plant species with
promising antiplasmodial activity (EC50 < 10.0 μg/ml),
were subjected to MTT cytotoxicity assay and tested
Table 4 The antiplasmodial and cytotoxicity activities of DCM, MeOH and H2O extracts of selected Malaysian medicinal
plants
Plant name Parts Extracts EC50 (μg/ml) Selectivity
index (SI)P. falciparum K1 MDBK cells
Curcuma zedoaria Rhizomes DCM 2.38 37.61 15.92
MeOH >15.70 NT ND
H2O >15.70 NT ND
Vernonia amygdalina Leaves DCM 3.36 157.69 47.00
MeOH 1.09 >300 >274.39
H2O 8.23 >600 >72.95
Alpinia galanga Rhizomes DCM 1.64 3.92 2.40
MeOH 8.06 87.95 10.92
H2O 1.84 >50 >27.16
Brucea javanica Leaves DCM 0.55 15.13 27.64
MeOH 5.27 87.95 16.70
H2O 1.29 1.90 1.48
Roots DCM 0.47 6.54 14.05
MeOH 0.58 6.95 12.06
H2O 4.49 9.59 2.14
Green seeds DCM >15.70 NT ND
MeOH 0.25 NT ND
H2O 1.47 NT ND
Black seeds DCM >15.70 NT ND
MeOH 1.96 7.70 3.92
H2O 5.40 24.24 4.49
Leea indica Leaves DCM >15.70 NT ND
MeOH >15.70 NT ND
H2O >15.70 NT ND
Cinnamomun iners Leaves DCM 1.95 199.15 102.58
MeOH 0.63 >400 >636.61
H2O 0.62 >100 >161.29
Vitex negundo Leaves DCM 1.10 25.04 22.80
MeOH 2.17 >50 >23.10
H2O >15.70 NT ND
Terminalia catappa Leaves DCM 5.29 >50 >9.45a
MeOH 5.19 >50 >9.63a
H2O 4.28 25.02 5.84
Morinda elliptica Leaves DCM 9.08 >50 >5.51a
MeOH 7.76 >50 >6.45a
H2O 0.50 31.05 62.10
Annona muricata Leaves DCM 0.61 40.48 66.47
MeOH 0.26 >100 >387.60
H2O 0.27 >200 >756.14
Curcuma mangga Rhizomes DCM 6.59 36.66 4.09
MeOH 1.81 >50 15.44
H2O 2.30 31.85 11.27
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Table 4 The antiplasmodial and cytotoxicity activities of DCM, MeOH and H2O extracts of selected Malaysian medicinal
plants (Continued)
Elephantopus scaber Leaves DCM 3.71 8.89 11.27
MeOH 0.27 42.75 2.39
H2O >15.70 NT ND
Roots DCM >15.70 NT ND
MeOH >15.70 NT ND
H2O >15.70 NT ND
Curcuma aeruginosa Rhizomes DCM 5.40 >50 >9.26a
MeOH 5.32 >50 >9.39a
H2O 4.78 >50 >10.46
Curcuma phaeocaulis Rhizomes DCM 5.00 11.04 2.21
MeOH 9.24 >50 >5.41a
H2O 10.45 NT ND
Data are presented as mean of at least two independent experiments performed in duplicate assays. DCM, dichloromethane; MeOH, methanol; H2O, water
extracts. No activity at the highest tested concentration denoted as EC50 > 15.70 μg/ml. No toxicity at the highest tested concentration denoted as EC50 > 50.00,
100, 200, 300, 400 and 600 μg/ml. SI: EC50 MDBK cell lines / EC50 Plasmodium.
aThe SI is not conclusive because the EC50 value is higher than 50 μg/ml which might
resulted in higher SI value. NT, not tested, ND, not determined.
In vitro P. falciparum HRP2 and MTT assays were conducted for each plant extracts on CQ resistant P. falciparum and MDBK cell line, respectively. The EC50 value
for each plants extracts were determined from the dose-response curves produced by using the HN-nonLin software (malaria.farch.net). The ratio of MDBK cell line
EC50 and P. falciparum EC50 of each extract give the SI index or the level of toxic effects. Twenty three extracts from 11 plant species showed promising
antiplasmodial activity (EC50 ≤ 10 μg/ml) with no toxic effect (SI ≥ 10).
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pharmacological efficacy of the extracts is considered se-
lective and nontoxic when SI is ≥10 [43]. Twenty three
of antiplasmodial plant extracts (DCM, MeOH or H2O)
from 11 plant species showed a specific selectivity (SI
>10) towards chloroquine resistant P. falciparum, K1 ra-
ther than MDBK cells with SI ranging from 10.46 to
756.14 (Table 4). The extract from B. javanica green
seed was not tested for MTT assay and has been ex-
cluded from this experiment.
Discussion
The present study has identified the antiplasmodial activ-
ity in selected plant extracts by HRP2-based assay or
HRP2 ELISA technique. There are other reports on anti-
plasmodial studies using different screening methods such
as WHO schizont maturation test [44], isotopic assay [45],
pLDH enzymatic assay [46,47], SYBR Green I assay
[48-50] or fluocytometric assay [51]. Briefly, the HRP2-
based assay is a very sensitive and specific measures of P.
falciparum growth by quantifying parasite specific biomol-
ecule, HRP2. The suitability, reproducibility and sensitivity
of HRP2-based assay in antimalarial drug screening is well
documented since year 2002 [16,39,52-55]. The HRP2-
based assay is comparable with other techniques because
the result produced by this assay has been previously
shown to be closely parallel those obtained from the iso-
topic assay, traditional WHO schizont maturation tests
[54] and SYBR green I assay [56].
Eleven plants (79%) were identified to possess promis-
ing antimalarial properties in at least one of theirextracts (DCM, MeOH or H2O). These findings are
based on their potent antiplasmodial activities (EC50 ≤
10 μg/ml) and high preferences in killing the malaria
parasite rather than mammalian cell line (SI ≥10)
(Table 4). Most of the potential antiplasmodial activity
were exhibited by DCM and MeOH extracts which may
be related to the presence of alkaloids, terpenoids and
flavonoids [57,58]. Theoretically, the purpose of using this
extraction technique is to extract specific classes of phyto-
chemical constituents from non-polar compounds to
polar compounds [59]. The crude extract of DCM usually
contains intermediate polarity of compounds such as alka-
loids, steroids and terpenoids [59-61]. These classes of
compounds especially alkaloids are well known as active
constituents against antiplasmodial activity. In fact, one of
the oldest and most known antimalarial drug, quinine be-
longs to this class of compounds. In addition, an example
of common terpenoids is artemisinin, the most potent
antimalarial to date [58]. Extraction with methanol will ex-
tract more polar compounds such as flavonoid glycosides,
saponin, tannins and anthocyanins [59-61]. The antimalar-
ial activity from these classes of compounds especially fla-
vonoids have been described earlier [57]. Further
extraction with water will extract high polarity of com-
pounds such as phenolic acids, sugars and glycosides
[59-61].
In another point of view, majority of these plants also
possessed at least 1% of CQ antiplasmodial activity indi-
cating the potential of these plants to be the source of
antimalarial candidates. For example, the ethanolic extract
of Artemisia annua Linn leaves (the source of artemisinin)
Table 5 The summary of antiplasmodial level of extracts from different parts of 14 plant species
Antiplasmodial level Plant species Parts Extracts
Good EC50 = 0.1-1.0 μg/ml A. muricata Leaves DCM, MeOH, H2O
B. javanica Green seeds MeOH
Roots DCM, MeOH
Leaves DCM
E. scaber Leaves MeOH
M. elliptica Leaves H2O
C. iners Leaves H2O, MeOH
Good to moderate EC50 = 1.1- 10 μg/ml V. amygdalina Leaves DCM, MeOH and H2O
A. galanga Rhizomes DCM, MeOH and H2O
T. catappa Leaves DCM, MeOH and H2O
C. mangga Rhizomes DCM, MeOH and H2O
C. aeruginosa Rhizomes DCM, MeOH and H2O
C. zedoaria Rhizomes DCM
E. scaber Leaves DCM
B. javanica Leaves MeOH and H2O
Roots H2O
Green seeds H2O
Black seeds MeOH and H2O
C. iners Leaves DCM
V. neguno Leaves DCM and MeOH
M. elliptica Leaves DCM and MeOH
C. phaeocaulis Rhizomes DCM and MeOH
Weak EC50 = 11-25 μg/ml C. phaeocaulis Rhizomes H2O
B. javanica Green seeds DCM
Black seeds DCM
L. indica Leaves DCM, MeOH and H2O
C. zedoaria Rhizomes MeOH and H2O
V. negundo Leaves H2O
E. scaber Leaves H2O
Roots DCM, MeOH and H2O
The level of efficacy of extracts were ranked according EC50 values which based on the threshold for in vitro antiplasmodial activity proposed by Rasoanaivo et al.
[41]. Forty one extracts from 13 plant species were categorized to have good and good to moderate antiplasmodial level.
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tive (3D7) strains of P. falciparum with IC50 of 10.4 μg/ml
and 21.8 μg/ml, respectively [49]. So, even the plant like
A. annua with weak antiplasmodial activity (only 0.007%
and 0.004% of artesunate activity against P. falciparum K1
and 3D7, respectively) contains the most potent antimal-
arial compound to date. This phenomenon may also apply
to the plants extracted in this study.
In this study, A. galanga (rhizome), C. iners (leaf ), C.
zedoaria (rhizome), E. scaber (leaf ), C. mangga (rhi-
zome) and M. elliptica (leaf ) were for the first time re-
ported for their good level of antiplasmodial activities
in vitro. Other potent antiplasmodial plants such as C.
aeruginosa (rhizome) [62], V. negundo (leaf ) [46], B.javanica (leaf and root) [45,51,62], A. muricata (leaf) [63]
and V. amygdalina (leaf) [44,64-68] have been widely
studied and were further discussed in this section.
A. galanga
The A. galanga has been identified as one of the plants
traditionally used in some part of Peninsular Malaysia
[11]. The in vitro antiplasmodial data of A. galanga rhi-
zome extracts (EC50 < 10 μg/ml) reported by present
study is complementing the in vivo study conducted by
Al-Adhroey et al. [11]. The MeOH extract of the rhi-
zome exhibited a significant suppressive, curative and
prophylactic activities on P. berghei infected mice. The
antimalarial properties of MeOH extract of A. galanga
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such as flavonoids and terpenoids [18]. In addition, both
terpenoids and flavonoids related compounds have been
previously shown to exhibit antiplasmodial activities
against several P. falciparum strains [57].
E. scaber
In this study, the good level of antiplasmodial activity
showed by the MeOH extract of E. scaber leaf (EC50 =
0.27 μg/ml) was contradictory to the study reported by
Kantamreddi and Wright [46]. According to Kantamreddi
and Wright [46], the MeOH extract of the leaves of this
plant was considered inactive (IC50 = 133.8 μg/ml) against
CQ resistant P. falciparum (K1) [46]. The possible reason
for the contradictory results could be due to the differ-
ences in the duration of incubation in antiplasmodial
assay. The incubation period for the present study is lon-
ger (72 hours) than the Kantamreddi and Wright [46]
study (48 hours). The 72 hours incubation period allows
the activity of the substance to affect the merozoite reinva-
sion process whereas the 48 hours incubation period will
only affect the intraerythrocytic growth of the malaria par-
asites. In this case, the MeOH extract of this plant might
not so effective against the ring to schizont intraerythrocy-
tic stages of P. falciparum. Other species of Elephantopus
such as E. mollis have been shown to possess potential
antiplasmodial activity (IC50 = 2.2 μg/ml) against CQ re-
sistant P. falciparum (K1) [69].
M. elliptica
To our knowledge, this plant had not yet been investigated
for the in vitro antiplasmodial activity. However other spe-
cies of Morinda, M. morindoides has been shown to ex-
hibit a pronounced antiplasmodial activity [64].
C. iners
The only antiplasmodial study on C. iners was previously
reported for its roots extract. However, the MeOH ex-
tract of C. iners roots exhibited weak antiplasmodial ac-
tivity (IC50 = 12.7 μg/ml) against CQ resistant P.
falciparum (FCR-3) [21]. In contrast, the leaves extract
(MeOH) of this plant which was prepared by present
study exhibited a good antiplasmodial activity (EC50 =
0.63 μg/ml) (Table 4). In addition, other Cinnamomun
species, C. griffithii has been reported to elicit a promis-
ing antiplasmodial activity (IC50 < 10 μg/ml) against both
CQ sensitive and resistant P. falciparum strains [70]. To
our knowledge, there is no compound related to this
plant reported for antiplasmodial activity.
Curcuma sp.
The member of the Curcuma plant species such as C.
zedoaria, C. mangga, C. aeruginosa and others were well
studied for their antiparasiticidal properties [71]. TheH2O extracts of C. xanthorriza and C. aeruginosa were
previously found to be effective in inhibiting P. falcip-
arum in vitro (40% and 90% inhibition, respectively).
However the concentration of the extracts used (1 mg/ml)
was too high [62]. Moreover, the major antiplasmodial
compounds like curcumin and its derivatives such as de-
methoxycurcumin and bis-demethoxycurcumin isolated
from C. longa exhibited high IC50 value (IC50 > 5 μM)
[72]. In contrast, by different technique of plant extrac-
tion, the present study showed a promising antiplasmo-
dial activity (EC50 < 10 μg/ml) of C. zedoaria (DCM
extract), C. aeruginosa (H2O extract) and C. mangga
(MeOH and H2O extracts) with negligible toxic effect on
normal cell line (SI >10) (Table 4 and 5). Although the
antiplasmodial activity of Curcuma sp isolated compound
such as curcumin is considered weak, it was found to be
very effective in antimalarial drug combination study
[15,73-75].
V. amygdalina
The V. amygdalina plant is also found in African coun-
tries and is widely used traditionally in treating fever,
malaria, measles, diabetes, worms, hypertension and
others [76,77]. The ethanol, petroleum ether, methylene
chloride and MeOH extracts of V. amygdalina leaf have
been previously reported to elicit IC50 values of less than
10 μg/ml against P. falciparum [64,65]. Both ethanolic
and H2O extracts of V. amygdalina leaf has also been
shown to inhibit schizont maturation of fresh P. falcip-
arum isolates from patients with negligible toxicity in
rats [44]. In addition, the in vivo antimalarial activity of
this plant has also been reported [66-68]. In in vivo drug
combination experiment, the decoction of V. amygda-
lina leaves has the ability to enhance the CQ activity in
P. berghei infected mice [68]. Furthermore, the infusion
of V. amygdalina leaves has been clinically tested against
the uncomplicated malaria where the parasite clearance
has been documented [78]. So, it is not surprising to see
a promising antiplasmodial activity of V. amygdalina leaf
extracts (DCM, MeOH and H2O extracts) as showed by
the present study (EC50 < 10 μg/ml) (Table 4). The anti-
malarial property of this plant could be due to the pres-
ence of its active constituents, sesquiterpene lactones
such as vernolepin, vernolin, vernolide, vernodalin and
hydroxyvernodalin [79].
B. javanica
The B. javanica grows in Asia Pacific region including
China, Indonesia, Malaysia and Thailand [45]. Different
parts of this plant such as fruit, roots, seeds, stems and
bark are traditionally used in treating variety of diseases
including babesiosis, malaria and cancer. The H2O ex-
tract of B. javanica leaves, fruits and bark have been
shown to possess a strong antiplasmodial activity against
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MeOH extracts of B. javanica leaves and roots showed
good (EC50 < 1 μg/ml) to good to moderate (EC50 = 1.1
to 10 μg/ml) level of antiplasmodial activities against CQ
resistant P. falciparum, K1 (Table 4). By similar extrac-
tion procedure, the DCM, MeOH and H2O extracts B.
javanica roots have also been previously reported to
possess a good to moderate level antiplasmodial activity
against another CQ resistant P. falciparum strain, W2
with IC50 ranging from 1.0 to 2.0 μg/ml [51]. The anti-
plasmodial activity showed by this plant might be gov-
erned by its active constituents such as quassinoids,
alkaloids (bruceacanthinoside) and triterpenoids (Bru-
ceajavanin A and dihydrobruceajavanin A) [80,81]. Other
plant from the same family (Simaroubaceae) like E. long-
ifolia also exhibited an antiplasmodial activity ruled by
its quassinoids and alkaloids contents [25,82]. In
addition, the present study has identified the antiplas-
modial activity from seeds of this plant (MeOH and
H2O extracts). However, the DCM extract of the seeds
seem to have weak or no antiplasmodial activity (EC50 >
15.7 μg/ml) (Table 4). In another study with different ex-
traction procedure, the extracts of B. javanica fruits
(ethanol, MeOH-ethanol, aqueous-MeOH residue, ethyl
acetate and ethyl alcohol extracts) have been shown to
have a promising antiplasmodial activity against P. fal-
ciparum K1 strain (IC50 < 10 μg/ml). In contrast, the
H2O extract of the fruits showed weak antiplasmodial
activity (IC50 > 10 μg/ml) [45].
V. negundo
The V. negundo has been traditionally used in India as
antiseptic, anti-inflammatory, antipyretic, treating en-
largement of spleen and others [83]. The present study
has highlighted the potential antiplasmodial activity of
DCM (EC50 = 1.1 μg/ml) and MeOH (EC50 = 2.17 μg/ml)
extracts of V. negundo leaves against the CQ resistant P.
falciparum. The MeOH extracts of V. negundo leaf has
been previously shown to exhibit a promising antiplas-
modial activity against CQ sensitive (IC50 = 9.5 μg/ml) P.
falciparum but not to CQ resistant P. falciparum strain
(IC50 = 19.8 μg/ml). In similar study, the MeOH extract
of the flower of this plant also exhibited a promising
antiplasmodial activity with IC50 value of against CQ
sensitive (IC50 = 2.8 μg/ml) but not to CQ resistant P.
falciparum (IC50 = 17.8 μg/ml) [46].
A. muricata
As reported by Osorio et al. [63], the hexane, ethyl acet-
ate and MeOH extract of A. muricata leaf exhibited
good to moderate level of antiplasmodial activities
against CQ sensitive P. falciparum strain F32 (IC50 ran-
ging from 7.2 to 9.2 μg/ml) but not to CQ resistant
strain W2 (IC50 ranging from 10.4 to 38.6 μg/ml) [63].However, the most potent ethyl acetate extracts of this
plant is considered toxic to U-937 cells (human mono-
cytes) (SI = 1.1 and 0.2 for F32 and W2 P. falciparum
strains, respectively). On the other hand, with different ex-
traction approach, the present study not only showing the
promising antiplasmodial activity of A. muricata leaves ex-
tracts (DCM, MeOH and H2O extracts) (EC50 < 10 μg/ml),
but also the non-toxic activity of the extract to MDBK cells
(SI = 66-756) (Table 4 and 5).
Conclusions
Twenty three extracts derived from C. zedoaria (rhi-
zome), C. aeruginosa (rhizome), A. galanga (rhizome),
V. negundo (leaf ), M. elliptica (leaf ), C. mangga (rhi-
zome), E. scaber (leaf ), B. javanica (leaf and root), A.
muricata (leaf ), C. iners (leaf ) and V. amygdalina (leaf )
showed the best antiplasmodial activities against the
blood stage chloroquine resistant P. falciparum with no
toxic effects on MDBK cells (SI ≥ 10). The present
study has also scientifically supported the efficacy of B.
javanica and A. galanga which are used traditionally to
treat malaria in Peninsular Malaysia. Although these
plant extracts were able to kill the P. falciparum
in vitro, further in vivo evaluation is needed to demon-
strate their efficacy in treating mammalian malaria
model. Furthermore, the bioassay guided fractionation
is a way forward for determination of bioactive com-
pounds which will lead to the formulation of new anti-
malarial drugs or standardized antimalarial extracts.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MRMAR involves manuscript preparation, data interpretation and analysis. AA
and RA carried out the plant extraction and cytotoxicity test. NFAJ involves in
antiplasmodial screening of plant extracts and data analysis. MIW involves in
consultation of plant extraction procedure. SHSZ involves in the preparation of
plant specimens for species identification. NRA contributes in overall project
design and concept. ZI involves in revising and giving the final approval of the
version to be published. All authors read and approved the final manuscript.
Authors’ information
All the authors are researchers from Bioassay and Phytochemistry Units of
Herbal Medicine Research Centre, Institute for Medical Research, Kuala
Lumpur, Malaysia.
Acknowledgements
The authors would like to thank the Director General of Health Malaysia for the
permission to publish this paper. We thank the Director for the Institute for
Medical Research (IMR), Kuala Lumpur for her critical review and support in
publishing this paper. The authors also wish to thank the staff of Phytochemistry
and Information Units, Herbal Medicine Research Centre, IMR, Kuala Lumpur who
has contributed in this study. This study, NMRR-13-424-16108 was supported by
the National Institute of Health, Ministry of Health Malaysia.
Received: 3 March 2014 Accepted: 11 December 2014
Published: 15 December 2014
References
1. Abdullah NR, Norahmad NA, Jelip J, Sulaiman LH, Mohd Sidek H, Ismail Z,
Noedl H: High prevalence of mutation in the Plasmodium falciparum dhfr
Mohd Abd Razak et al. BMC Complementary and Alternative Medicine 2014, 14:492 Page 12 of 13
http://www.biomedcentral.com/1472-6882/14/492and dhps genes in field isolates from Sabah, Northern Borneo. Malar J
2013, 12(1):198.
2. Norahmad NA, Abdullah NR, Yaccob N, Jelip J, Dony JF, Ruslan KF, Sulaiman
LH, Sidek HM, Noedl H, Ismail Z: High prevalence of pfcrt K76t mutants
among Plasmodium falciparum isolates from Sabah, Malaysia. Southeast
Asian J Trop Med Public Health 2011, 42(6):1322–1326.
3. Lokman Hakim S, Sharifah Roohi SW, Zurkurnai Y, Noor Rain A, Mansor SM,
Palmer K, Navaratnam V, Mak JW: Plasmodium falciparum: increased
proportion of severe resistance (RII and RIII) to chloroquine and high
rate of resistance to sulfadoxine-pyrimethamine in Peninsular Malaysia
after two decades. Trans R Soc Trop Med Hyg 1996, 90(3):294–297.
4. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo
C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ,
Anderson TJ, Nosten F: Emergence of artemisinin-resistant malaria on the
western border of Thailand: a longitudinal study. Lancet 2012,
379(9830):1960–1966.
5. Baliraine FN, Rosenthal PJ: Prolonged selection of pfmdr1 polymorphisms
after treatment of falciparum malaria with artemether-lumefantrine in
Uganda. J Infect Dis 2011, 204(7):1120–1124.
6. Farnert A, Ursing J, Tolfvenstam T, Rono J, Karlsson L, Sparrelid E, Lindegardh N:
Artemether-lumefantrine treatment failure despite adequate lumefantrine
day 7 concentration in a traveller with Plasmodium falciparum malaria after
returning from Tanzania. Malar J 2012, 11:176.
7. Wongsrichanalai C, Sibley CH: Fighting drug-resistant Plasmodium
falciparum: the challenge of artemisinin resistance. Clin Microbiol Infect
2013, 19(10):908–916.
8. Wongsrichanalai C: Artemisinin resistance or artemisinin-based combination
therapy resistance? Lancet Infect Dis 2013, 13(2):114–115.
9. Na-Bangchang K, Muhamad P, Ruaengweerayut R, Chaijaroenkul W,
Karbwang J: Identification of resistance of Plasmodium falciparum to
artesunate-mefloquine combination in an area along the Thai-Myanmar
border: integration of clinico-parasitological response, systemic drug ex-
posure, and in vitro parasite sensitivity. Malar J 2013, 12:263.
10. Willcox M, Burford G, Bodeker G: An overview of ethnobotanical studies
on plants used for the treatment of malaria. In Traditional Medicinal Plant
and Malaria. Edited by Willcox M, Bodeker G, Rasoanaivo P. Florida: CRC
Press; 2004:187–197.
11. Al-Adhroey AH, Nor ZM, Al-Mekhlafi HM, Mahmud R: Ethnobotanical study
on some Malaysian anti-malarial plants: a community based survey.
J Ethnopharmacol 2010, 132(1):362–364.
12. Ong HC, Chua S, Milow P: Ethno-medicinal plants used by the Temuan
villagers in Kampung Jeram Kedah, Negeri Sembilan, Malaysia. Ethno
Med 2011, 5(2):95–100.
13. Ong HC, Nordiana M: Malay ethno-medico botany in Machang, Kelantan,
Malaysia. Fitoterapia 1999, 70:502–513.
14. Elfawal MA, Towler MJ, Reich NG, Golenbock D, Weathers PJ, Rich SM: Dried
whole plant Artemisia annua as an antimalarial therapy. PLoS One 2012,
7(12):e52746.
15. Rasoanaivo P, Wright CW, Willcox ML, Gilbert B: Whole plant extracts
versus single compounds for the treatment of malaria: synergy and
positive interactions. Malar J 2011, Suppl 1:S4.
16. Noedl H, Wernsdorfer WH, Miller RS, Wongsrichanalai C: Histidine-rich
protein II: a novel approach to malaria drug sensitivity testing. Antimicrob
Agents Chemother 2002, 46(6):1658–1664.
17. Noor Rain A, Khozirah S, Mohd Ridzuan MA, Ong BK, Rohaya C, Rosilawati
M, Hamdino I, Badrul A, Zakiah I: Antiplasmodial properties of some
Malaysian medicinal plants. Trop Biomed 2007, 24(1):29–35.
18. Al-Adhroey AH, Nor ZM, Al-Mekhlafi HM, Mahmud R: Median lethal dose,
antimalarial activity, phytochemical screening and radical scavenging of
methanolic Languas galanga rhizome extract. Molecules 2010,
15(11):8366–8376.
19. Wong SK, Lim YY, Abdullah NR, Nordin FJ: Assessment of antiproliferative
and antiplasmodial activities of five selected Apocynaceae species. BMC
Complement Altern Med 2011, 11:3.
20. Basir R, Chan KL, Yam MF, Othman F, Abdullah WO, Mohd Moklas MA,
Abdul Rahim AS, Ismail IS, Hidayat MT, Mat Taib CN, Mahmud R:
Antimalarial activity of selected Malaysian medicinal plants.
Phytopharmacology 2012, 3(1):82–92.
21. Wan Omar A, Ngah ZU, Zaridah MZ, Noor Rain A: In vitro and in vivo
antiplasmodial properties of some Malaysian plants used in traditional
medicine. Infect Dis J Pakistan 2007, 16(4):97–101.22. Siti Najila MJ, Noor Rain A, Mohamad Kamel AG, Syed Zahir SI, Khozirah S,
Lokman Hakim S, Zakiah I, Azizol AK: The screening of extracts from
Goniothalamus scortechinii, Aralidium pinnatifidum and Andrographis
paniculata for anti-malarial activity using the lactate dehydrogenase
assay. J Ethnopharmacol 2002, 82(2–3):239–242.
23. Al-Adhroey AH, Nor ZM, Al-Mekhlafi HM, Amran AA, Mahmud R: Evaluation
of the use of Cocos nucifera as antimalarial remedy in Malaysian folk
medicine. J Ethnopharmacol 2011, 134(3):988–991.
24. Nasrullah AA, Zahari A, Mohamad J, Awang K: Antiplasmodial alkaloids
from the bark of Cryptocarya nigra (Lauraceae). Molecules 2013,
18(7):8009–8017.
25. Chan KL, Choo CY, Abdullah NR, Ismail Z: Antiplasmodial studies of
Eurycoma longifolia Jack using the lactate dehydrogenase assay of
Plasmodium falciparum. J Ethnopharmacol 2004, 92(2–3):223–227.
26. Ang HH, Chan KL, Mak JW: In vitro antimalarial activity of quassinoids
from Eurycoma longifolia against Malaysian chloroquine-resistant
Plasmodium falciparum isolates. Planta Med 1995, 61(2):177–178.
27. Chan KL, Choo CY, Abdullah NR: Semisynthetic 15-O-acyl- and 1,15-di-O-
acyleurycomanones from Eurycoma longifolia as potential antimalarials.
Planta Med 2005, 71(10):967–969.
28. Vejanan V, Latip J, Chin LP, Embi N, Sidek HM: In vitro and in vivo anti-
plasmodial activities of Gynura procumbens. Sains Malaysiana 2012,
41(12):1535–1542.
29. Yapp DT, Yap SY: Lansium domesticum: skin and leaf extracts of this fruit
tree interrupt the lifecycle of Plasmodium falciparum, and are active
towards a chloroquine-resistant strain of the parasite (T9) in vitro.
J Ethnopharmacol 2003, 85(1):145–150.
30. Faridahanim MJ, Abdul Hamid AH, Khalijah A, Nor Hadiani I, Noor Rain A:
The screening of the extract from Leuconotis eugenifolius for antimalarial
activity using the lactate dehydrogenase assay. In Malaysian Medicinal
Plants: Chemistry and Biological Activity. 1st edition. Edited by Ahmad F,
Assim Z, Din L, Said IM. Sarawak, Malaysia: UNIMAS and Malaysian Natural
Products Society; 2006:23–26.
31. Zakaria I, Ahmat N, Jaafar FM, Widyawaruyanti A: Flavonoids with
antiplasmodial and cytotoxic activities of Macaranga triloba. Fitoterapia
2012, 83(5):968–972.
32. Awang K, Mukhtar MR, Hadi AH, Litaudon M, Latip J, Abdullah NR: New
alkaloids from Phoebe grandis (Nees) Merr. Nat Prod Res 2006, 20(6):567–572.
33. Al-Adhroey AH, Nor ZM, Al-Mekhlafi HM, Amran AA, Mahmud R: Antimalarial
activity of methanolic leaf extract of Piper betle L. Molecules 2011,
16(1):107–118.
34. Najib Nik ARN, Furuta T, Kojima S, Takane K, Ali Mohd M: Antimalarial
activity of extracts of Malaysian medicinal plants. J Ethnopharmacol 1999,
64(3):249–254.
35. Osman CP, Ismail NH, Ahmad R, Ahmat N, Awang K, Jaafar FM:
Anthraquinones with antiplasmodial activity from the roots of Rennellia
elliptica Korth. (Rubiaceae). Molecules 2010, 15(10):7218–7226.
36. Burkill IH: A Dictionary of the Economic Products of the Malay Peninsula,
Volume I and II. Ministry of Agriculture Malaysia: Kuala Lumpur, Malaysia;
1966.
37. Trager W, Jensen JB: Cultivation of erythrocytic stages. Bull World Health
Organ 1977, 55(2–3):363–365.
38. Lambros C, Vanderberg JP: Synchronization of Plasmodium falciparum
erythrocytic stages in culture. J Parasitol 1979, 65(3):418–420.
39. Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M: Simple
histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent
assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother
2005, 49(8):3575–3577.
40. Mosmann T: Rapid colorimetric assay for cellular growth and survival:
application to proliferation and cytotoxicity assays. J Immunol Methods
1983, 65(1–2):55–63.
41. Rasoanaivo P, Ramanitrahasimbola D, Rafatro H, Rakotondramanana D,
Robijaona B, Rakotozafy A, Ratsimamanga-Urverg S, Labaied M, Grellier P,
Allorge L, Mambu L, Frappier F: Screening extracts of Madagascan plants in
search of antiplasmodial compounds. Phytother Res 2004, 18(9):742–747.
42. Sidhu AB, Verdier-Pinard D, Fidock DA: Chloroquine resistance in Plasmodium
falciparum malaria parasites conferred by pfcrt mutations. Science 2002,
298(5591):210–213.
43. Weniger B, Robledo S, Arango GJ, Deharo E, Aragon R, Munoz V, Callapa J,
Lobstein A, Anton R: Antiprotozoal activities of Colombian plants.
J Ethnopharmacol 2001, 78(2–3):193–200.
Mohd Abd Razak et al. BMC Complementary and Alternative Medicine 2014, 14:492 Page 13 of 13
http://www.biomedcentral.com/1472-6882/14/49244. Sha'a KK, Oguche S, Watila IM, Ikpa TF: In vitro antimalarial activity of the
extracts of Vernonia amygdalina commonly used in traditional medicine
in Nigeria. Sci World J 2011, 6(2):5–9.
45. Sriwilaijaroen N, Kondo S, Nanthasri P, Auparakkitanon S, Suzuki Y, Wilairat P:
Antiplasmodial effects of Brucea javanica (L.) Merr. and Eurycoma longifolia
Jack extracts and their cobination with chloroquine and quinine on
Plasmodium falciparum in culture. Trop Med Health 2010, 38(2):61–68.
46. Kantamreddi VS, Wright CW: Screening Indian plant species for
antiplasmodial properties–ethnopharmacological compared with
random selection. Phytother Res 2012, 26(12):1793–1799.
47. Ondo JP, Lekana-Douki JB, Bongui JB, Zang Edou ES, Zatra R, Toure-Ndouo FS,
Elomri A, Lebibi J, Seguin E: In vitro antiplasmodial activity and cytotoxicity
of extracts and fractions of Vitex madiensis, medicinal plant of Gabon. Trop
Med Int Health 2012, 17(3):316–321.
48. Bagavan A, Rahuman AA, Kaushik NK, Sahal D: In vitro antimalarial activity
of medicinal plant extracts against Plasmodium falciparum. Parasitol Res
2011, 108(1):15–22.
49. Thiengsusuk A, Chaijaroenkul W, Na-Bangchang K: Antimalarial activities of
medicinal plants and herbal formulations used in Thai traditional medicine.
Parasitol Res 2013, 112(4):1475–1481.
50. Kamaraj C, Kaushik NK, Rahuman AA, Mohanakrishnan D, Bagavan A, Elango
G, Zahir AA, Santhoshkumar T, Marimuthu S, Jayaseelan C, Kirthi AV,
Rajakumar G, Velayutham K, Sahal D: Antimalarial activities of medicinal
plants traditionally used in the villages of Dharmapuri regions of South
India. J Ethnopharmacol 2012, 141(3):796–802.
51. Hout S, Chea A, Bun SS, Elias R, Gasquet M, Timon-David P, Balansard G,
Azas N: Screening of selected indigenous plants of Cambodia for
antiplasmodial activity. J Ethnopharmacol 2006, 107(1):12–18.
52. Noedl H, Yingyuen K, Laoboonchai A, Fukuda M, Sirichaisinthop J, Miller RS:
Sensitivity and specificity of an antigen detection ELISA for malaria
diagnosis. Am J Trop Med Hyg 2006, 75(6):1205–1208.
53. Noedl H, Attlmayr B, Wernsdorfer WH, Kollaritsch H, Miller RS: A histidine-
rich protein 2-based malaria drug sensitivity assay for field use. Am J
Trop Med Hyg 2004, 71(6):711–714.
54. Noedl H, Wernsdorfer WH, Kollaritsch H, Looareesuwan S, Miller RS,
Wongsrichanalai C: Malaria drug-susceptibility testing. HRP2-based assays:
current data, future perspectives. Wien Klin Wochenschr 2003,
115(Suppl 3):23–27.
55. Noedl H, Wongsrichanalai C, Miller RS, Myint KS, Looareesuwan S, Sukthana
Y, Wongchotigul V, Kollaritsch H, Wiedermann G, Wernsdorfer WH:
Plasmodium falciparum: effect of anti-malarial drugs on the production
and secretion characteristics of histidine-rich protein II. Exp Parasitol 2002,
102(3–4):157–163.
56. Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S: Comparison of a
SYBR green I-based assay with a histidine-rich protein II enzyme-linked
immunosorbent assay for in vitro antimalarial drug efficacy testing and
application to clinical isolates. Antimicrob Agents Chemother 2007,
51(4):1172–1178.
57. Batista R, Silva Ade J Jr, de Oliveira AB: Plant-derived antimalarial agents:
new leads and efficient phytomedicines. Part II. Non-alkaloidal natural
products. Molecules 2009, 14(8):3037–3072.
58. Oliveira AB, Dolabela MF, Braga FC, Jacome RL, Varotti FP, Povoa MM: Plant-
derived antimalarial agents: new leads and efficient phythomedicines.
Part I. Alkaloids. An Acad Bras Cienc 2009, 81(4):715–740.
59. Houghton PJ, Raman A: Laboratory Handbook for the Fractionation of
Natural Extracts. 1st edition. London: Chapman & Hall; 1998.
60. Tiwari P, Kumar B, Kaur M, Kaur G, Kaur K: Phytochemical screening and
extraction: A review. Internationale Pharmaceutica Sciencia 2011, 1(1):98–106.
61. Cowan MM: Plant products as antimicrobial agents. Clin Microbiol Rev
1999, 12(4):564–582.
62. Murnigsih T, Subeki, Matsuura H, Takahashi K, Yamasaki M, Yamato O,
Maede Y, Katakura K, Suzuki M, Kobayashi S, Chairul, Yoshihara T: Evaluation
of the inhibitory activities of the extracts of Indonesian traditional
medicinal plants against Plasmodium falciparum and Babesia gibsoni.
J Vet Med Sci 2005, 67(8):829–831.
63. Osorio E, Arango GJ, Jimenez N, Alzate F, Ruiz G, Gutierrez D, Paco MA,
Gimenez A, Robledo S: Antiprotozoal and cytotoxic activities in vitro of
Colombian Annonaceae. J Ethnopharmacol 2007, 111(3):630–635.
64. Tona L, Cimanga RK, Mesia K, Musuamba CT, De Bruyne T, Apers S, Hernans
N, Van Miert S, Pieters L, Totte J, Vlietinck AJ: In vitro antiplasmodialactivity of extracts and fractions from seven medicinal plants used in the
Democratic Republic of Congo. J Ethnopharmacol 2004, 93(1):27–32.
65. Zofou D, Tene M, Ngemenya MN, Tane P, Titanji VP: In vitro antiplasmodial
activity and cytotoxicity of extracts of selected medicinal plants used by
traditional healers of Western cameroon. Malar Res Treat 2011,
2011:561342.
66. Abosi AO, Raseroka BH: In vivo antimalarial activity of Vernonia
amygdalina. Br J Biomed Sci 2003, 60(2):89–91.
67. Njan AA, Adzu B, Agaba AG, Byarugaba D, Diaz-Llera S, Bangsberg DR: The
analgesic and antiplasmodial activities and toxicology of Vernonia
amygdalina. J Med Food 2008, 11(3):574–581.
68. Iwalokun BA: Enhanced antimalarial effects of chloroquine by aqueous
Vernonia amygdalina leaf extract in mice infected with chloroquine
resistant and sensitive Plasmodium berghei strains. Afr Health Sci 2008,
8(1):25–35.
69. Gachet MS, Lecaro JS, Kaiser M, Brun R, Navarrete H, Munoz RA, Bauer R,
Schuhly W: Assessment of anti-protozoal activity of plants traditionally
used in Ecuador in the treatment of leishmaniasis. J Ethnopharmacol
2010, 128(1):184–197.
70. Horgen FD, Edrada RA, de los Reyes G, Agcaoili F, Madulid DA, Wongpanich
V, Angerhofer CK, Pezzuto JM, Soejarto DD, Farnsworth NR: Biological
screening of rain forest plot trees from Palawan Island (Philippines).
Phytomedicine 2001, 8(1):71–81.
71. Haddad M, Sauvain M, Deharo E: Curcuma as a parasiticidal agent: a
review. Planta Med 2011, 77(6):672–678.
72. Rasmussen HB, Christensen SB, Kvist LP, Karazmi A: A simple and efficient
separation of the curcumins, the antiprotozoal constituents of Curcuma
longa. Planta Med 2000, 66(4):396–398.
73. Nandakumar DN, Nagaraj VA, Vathsala PG, Rangarajan P, Padmanaban G:
Curcumin-artemisinin combination therapy for malaria. Antimicrob Agents
Chemother 2006, 50(5):1859–1860.
74. Aditya NP, Chimote G, Gunalan K, Banerjee R, Patankar S, Madhusudhan B:
Curcuminoids-loaded liposomes in combination with arteether protects
against Plasmodium berghei infection in mice. Exp Parasitol 2012,
131(3):292–299.
75. Mishra K, Dash AP, Swain BK, Dey N: Anti-malarial activities of
Andrographis paniculata and Hedyotis corymbosa extracts and their
combination with curcumin. Malar J 2009, 8:26.
76. Toyang NJ, Verpoorte R: A review of the medicinal potentials of plants of
the genus Vernonia (Asteraceae). J Ethnopharmacol 2013, 146(3):681–723.
77. Tabuti JR: Herbal medicines used in the treatment of malaria in Budiope
county, Uganda. J Ethnopharmacol 2008, 116(1):33–42.
78. Challand S, Willcox M: A clinical trial of the traditional medicine Vernonia
amygdalina in the treatment of uncomplicated malaria. J Altern
Complement Med 2009, 15(11):1231–1237.
79. Phillipson JD, Wright CW, Kirby GC, Warhurst DC: Phytochemistry of some
plants used in traditional medicine for the treatment of protozoal
diseases. In International Symposium of the Phytochemical Society of Europe.
Lausanne, Switzerland: University of Lausanne; 1993:3.
80. Kitagawa I, Mahmud T, Simanjuntak P, Hori K, Uji T, Shibuya H: Indonesian
medicinal plants. VIII. Chemical structures of three new triterpenoids,
bruceajavanin A, dihydrobruceajavanin A, and bruceajavanin B, and a
new alkaloidal glycoside, bruceacanthinoside, from the stems of Brucea
javanica (Simaroubaceae). Chem Pharm Bull (Tokyo) 1994, 42(7):1416–1421.
81. O'Neill MJ, Bray DH, Boardman P, Chan KL, Phillipson JD, Warhurst DC,
Peters W: Plants as sources of antimalarial drugs, Part 4: Activity of
Brucea javanica fruits against chloroquine-resistant Plasmodium
falciparum in vitro and against Plasmodium berghei in vivo. J Nat Prod
1987, 50(1):41–48.
82. Kuo PC, Shi LS, Damu AG, Su CR, Huang CH, Ke CH, Wu JB, Lin AJ, Bastow
KF, Lee KH, Wu TS: Cytotoxic and antimalarial beta-carboline alkaloids
from the roots of Eurycoma longifolia. J Nat Prod 2003, 66(10):1324–1327.
83. Tandon VR: Medicinal uses and biological activities of Vitex negundo.
Natural Product Radiance 2005, 4(3):162–165.
doi:10.1186/1472-6882-14-492
Cite this article as: Mohd Abd Razak et al.: Effect of selected local
medicinal plants on the asexual blood stage of chloroquine resistant
Plasmodium falciparum. BMC Complementary and Alternative Medicine
2014 14:492.
